Back to search
FDAFDA · Food and drugs·Recall number D-1481-2016

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 5 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-874-25; Blister NDC 68084-874-95

Published September 14, 2016 · Recall initiated: August 24, 2016

Summary

FDA records drug Class II recall D-1481-2016, published September 14, 2016 and initiated August 24, 2016. Recalling firm: Amerisource Health Services; Status: Terminated; Reported quantity: 221 cartons; Lot: Lot 163220, exp. 10/31/17 and lot 164194, exp. 11/20/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Amerisource Health Services
Distributor
Product was distributed in the following states: Nationwide
Lot
Lot 163220, exp. 10/31/17 and lot 164194, exp. 11/20/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate Tablets (Mixed Salts of a Single Entity Amphetamine Product) CII 5 mg, 30 UD Tablets (5 x 6), Rx, Packaged and Distributed by: American Health Packaging, Columbus, OH --- Carton NDC 68084-874-25; Blister NDC 68084-874-95 recalled?

Yes. FDA published recall D-1481-2016 on September 14, 2016. Reported hazard: Unit Dose Mispackaging; blister cavities may contain more than one tablet /capsule

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail